Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
400 participants
OBSERVATIONAL
2025-05-13
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries
NCT04322370
Effect of Autologous Conditioned Plasma Treatment for Conservative Treated Total Achilles Tendon Tears
NCT02417922
Impact of Negative Pressure Wound Therapy on Free Muscle Flaps
NCT02526342
Effects of TENS Therapy Following Arthroscopic Knee Surgery
NCT01528228
A Comparison of ThermaWedge™ Device and Achilles Tendon Stretching for the Treatment of Plantar Fasciopathy
NCT02518841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VersaWrap
All enrolled patients will received VersaWrap applied prior to surgical closure on the affected tendon.
VersaWrap
VersaWrap is applied to the affected tendon to allow post-operative gliding.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VersaWrap
VersaWrap is applied to the affected tendon to allow post-operative gliding.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to understand the requirements of the study, provide a written consent, and willing to comply with the study protocol
3. Age ≥18 years and \<90 years at the time of surgery
Exclusion Criteria
2. Active systemic infection or infection at the location planned surgery
3. Uncontrolled diabetes
4. Prior Achilles surgery on either ankle
5. Active or suspected malignancy. If symptom free for 2 years, patients with prior malignancy may be included
6. Morbid obesity defined as a body mass index \> 40
7. Pregnant or have plans to become pregnant in the next year
8. Currently a prisoner
9. Autoimmune disorders that impact the musculoskeletal system (e.g., lupus, rheumatoid arthritis; ankylosing spondylitis)
10. Medications that could interfere with fusion or other bone/soft tissue healing (e.g., anticipated continued use of systemic steroid medication postoperatively)
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Source
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC Davis Foot and Ankle Orthopaedics Clinic
Sacramento, California, United States
Rothman Orthopaedics Institute
Philadelphia, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TP-068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.